An apparently autosomal recessive syndrome of congenital renal tubular dysplasia and skull ossification defects is described in five infants from two separate, consanguineous, Pakistani Muslim kindreds. The clinical, pathological, and radiological features are similar to the phenotype associated with fetal exposure to angiotensin converting enzyme (ACE) inhibitors: intrauterine growth retardation, skull ossification defects, and fetal/ neonatal anuric renal failure associated with renal tubular dysplasia. There was no fetal exposure to ACE inhibitors in the affected infants. Phenotypic similarities between these familial cases and those associated with ACE inhibition suggest an abnormality of the "renin-angiotensinaldosterone" system (RAS). It is postulated that the molecular pathology in this uncommon autosomal recessive proximal renal tubular dysgenesis could be related to mutations of the gene systems governing the RAS. 
to angiotensin converting enzyme (ACE) inhibitors: intrauterine growth retardation, skull ossification defects, and fetal/ neonatal anuric renal failure associated with renal tubular dysplasia. There was no fetal exposure to ACE inhibitors in the affected infants. Phenotypic similarities between these familial cases and those associated with ACE inhibition suggest an abnormality of the "renin-angiotensinaldosterone" system (RAS). It is postulated that the molecular pathology in this uncommon autosomal recessive proximal renal tubular dysgenesis could be related to mutations of the gene systems governing the RAS. Keywords: proximal renal tubular dysplasia; reninangiotensin system (RAS); angiotensin converting enzyme (ACE) inhibitors; fetal ACE inhibitors syndrome Several reports of primary renal tubular dysplasia (RTD)' have been published since the original description.2 Recurrence in sibs3 and parental consanguinity5 favour autosomal recessive inheritance (MIM 267430) .1 The precise molecular mechanism leading to the phenotype of RTD is not clear. The putative gene(s) is yet to be mapped and cloned.
This report describes five infants from two unrelated consanguineous Muslim families presenting with multiple congenital anomalies (MCA) including RTD. The purposes of this report are to delineate further the phenotype of autosomal recessive RTD and to draw attention to striking similarities with the teratogenic effects of maternal administration of angiotensin converting enzyme (ACE) inhibitors (for example, captopril, enalapril), which include skull ossification defects and anuric neonatal renal failure.6 7 The phenotype of "fetal ACE inhibitors syndrome" is now Biochemical investigations showed high PRA and low angiotensin I levels. Molecular genetic investigations showed the child to be a The mechanism of inherited proximal RTD and its associated findings have not been elucidated. In our cases, investigations in infants IV.4 (family 1) and IV.2 (family 2) showed evidence of raised renin activity in both, together with a low level of angiotensin I (Ang I) in infant IV.2 (family 2). Unfortunately, further investigation in the affected families was precluded by insufficient blood samples. The raised plasma renin activity suggests activation of the RAS as might be expected in sick, hypotensive neonates. However, a low Ang I would suggest a block in the RAS which may in turn be the primary cause of the profound hypotension. Possible causes of this combination of findings include a qualitative abnormality of the circulating renin or a quantitative or qualitative abnormality of angiotensinogen which may be related to an abnormality in the angiotensin gene system (1 q42-q44). It is interesting to speculate how these or the consequent abnormalities further down the pathway of the RAS could generate the clinical findings (fig 5) . Consideration of the fetal ACE inhibitor syndrome may provide further insight.
There is striking similarity between the phenotype of inherited proximal RTD and the spectrum of developmental abnormalities resulting from probable teratogenic effects of ACE inhibitors.6 7 15-18 Concerns about possible adverse fetal effects of ACE inhibitors were raised soon after their introduction as antihypertensive agents.'9 20 Fetal ACE inhibitor syndrome is now accepted as an entity whose major features are intrauterine growth retardation, skull ossification defects, and proximal renal tubular dysgenesis.8 There is an associated increased incidence of intrauterine deaths, stillbirths, and perinatal deaths which have been ascribed to oligohydramnios, fetal hypotension, and fetal/neonatal anuric renal failure. The latter has been considered secondary to decreased pressure and blood flow in the efferent glomerular arteriole secondary to decreased levels of angiotensin II (Ang II). This in turn is thought to contribute to the maldevelopment of the renal tubules ( fig 6) vitro studies has investigated the effect of low RAS activity or Ang II levels. Nevertheless, it is interesting to hypothesise that this may contribute to proximal tubular dysgenesis via an effect on regulation of nephronal growth in addition to any changes in glomerular haemodynamics. The role of Ang II in the induction of early genes remains to be proven, but a lack of Ang II may conceivably contribute to the embryopathy seen in both inherited proximal RTD and the fetal ACE inhibitor syndrome.
We believe that this report shows the similarities between the uncommon genetic syndrome of autosomal recessive proximal RTD and the drug induced phenotype associated with fetal exposure to ACE inhibitors. Our limited investigations have not identified a specific gene abnormality in the former. Consideration of the available results together with knowledge of the fetal ACE inhibitor syndrome and functions of Ang II has led us to suggest that an abnormality in the RAS may be a fundamental problem in inherited proximal RTD. The angiotensinogen gene system may be a likely candidate gene, although others within the RAS may be responsible. More detailed investigation of the RAS in further cases is needed to establish whether this is true and to delineate the molecular pathology of the syndrome of autosomal recessive proximal RTD.
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